SenzoHealth

The headline is clear; we need better rapid self-tests for existing pandemics like Tuberculosis, and future pandemics we are yet to encounter. At Senzo we are building the high-accuracy diagnostics today that we will urgently need tomorrow. Full study: thelancet.com/journals/lanin…

𝗧𝗵𝗶𝘀 𝗶𝘀 𝘄𝗵𝘆 𝘄𝗲 𝗮𝗿𝗲 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗶𝗻𝗴 𝗣𝗖𝗥-𝗮𝗰𝗰𝘂𝗿𝗮𝘁𝗲 𝗹𝗮𝘁𝗲𝗿𝗮𝗹 𝗳𝗹𝗼𝘄 𝗱𝗲𝘃𝗶𝘀𝗲 𝘁𝗲𝘀𝘁𝘀. A new study by @TheLancet puts Lateral Flow Devise sensitivity for alpha, delta, and omicron Covid waves at just 63·2%.

Whilst most articles currently focus on how AI will replace your job, we're interested in how AI will diagnose your cancer, virus, infection, and illness.

𝗧𝗵𝗲 𝗲𝗮𝗿𝗹𝗶𝗲𝗿 𝘄𝗲 𝗰𝗮𝗻 𝗱𝗲𝘁𝗲𝗰𝘁, 𝘁𝗵𝗲 𝗲𝗮𝗿𝗹𝗶𝗲𝗿 𝘄𝗲 𝗰𝗮𝗻 𝘁𝗿𝗲𝗮𝘁, 𝘁𝗵𝗲 𝗲𝗮𝗿𝗹𝗶𝗲𝗿 𝘄𝗲 𝗰𝗮𝗻 𝗰𝘂𝗿𝗲. unilad.com/technology/ai-…

#ageingpopulation #globalchallenge #healthcare #futurerequirements #demographicchange #elderlycare #populationgrowth #agingdemographic

Simple, accurate and affordable diagnostics, which can be tuned to a range of targets, providing both reliable testing and rolling surveillance will provide a valuable solution for future requirements.

𝗗𝗲𝘀𝗶𝗴𝗻 𝘁𝗼𝗱𝗮𝘆 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗿𝗲𝗾𝘂𝗶𝗿𝗲𝗺𝗲𝗻𝘁𝘀 𝗼𝗳 𝘁𝗼𝗺𝗼𝗿𝗿𝗼𝘄. By 2025, 11% of the global population, and 21% of the European population, will be over 65 years old. This ageing demographic will increase the demand for healthcare.

Announcement: 𝗦𝗲𝗻𝘇𝗼 𝗮𝗻𝗱 𝗔𝗯𝗶𝗻𝗴𝗱𝗼𝗻 𝗛𝗲𝗮𝗹𝘁𝗵 𝗘𝗻𝘁𝗲𝗿 𝗜𝗻𝘁𝗼 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗣𝗮𝗿𝘁𝗻𝗲𝗿𝘀𝗵𝗶𝗽. Abingdon Health's CDMO service to support Senzo in leveraging its innovative, high-accuracy Amplified Lateral Flow (ALF) platform. newswire.com/news/senzo-and…

Detailed analysis of the study in @CNN and @WSJ articles below: #ProstateCancer #Surveillance #ActiveMonitoring #Testing #MedicalResearch #MensHealth wsj.com/articles/prost… edition.cnn.com/2023/03/11/hea….

For the 11% of US men who will be diagnosed with prostate cancer, a new study shows surveillance and active monitoring is often the best approach for non-aggressive cancers. From monitoring to diagnosing, the better our testing, the better our decisions.

𝟭/𝟯𝗿𝗱 𝗼𝗳 𝘁𝗵𝗲 𝘄𝗼𝗿𝗹𝗱'𝘀 𝗽𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗶𝘀 𝗶𝗻𝗳𝗲𝗰𝘁𝗲𝗱 𝘄𝗶𝘁𝗵 𝗧𝘂𝗯𝗲𝗿𝗰𝘂𝗹𝗼𝘀𝗶𝘀. Here are 3 of the most important organisations currently working to bring an end to this pandemic; @WHO @USAID @GlobalFund

To learn more about how Senzo is working to create better diagnostics to help end the current TB pandemic please get in touch. #EndTBTogether #TBTreatment #TBInfectionRates #DiagnosticsMatter #WHO #TBGlobalElimination Source: gov.uk/government/pub…

This strategy committed to decreasing the number of people afflicted with TB by 90%, reducing TB-related deaths by 95%, and protecting families from the adverse effects of the disease. Whilst lots has been achieved, much remains to be done.

𝗧𝘂𝗯𝗲𝗿𝗰𝘂𝗹𝗼𝘀𝗶𝘀 𝗶𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻 𝗿𝗮𝘁𝗲𝘀 𝗯𝘆 𝗰𝗼𝘂𝗻𝘁𝗿𝘆 (𝗪𝗛𝗢, 𝟭-𝟭𝟬). In 2014, the WHO endorsed the End TB Strategy to eradicate tuberculosis globally by 2035.

The faster we can diagnose, the faster we can treat. Learn more about our work at senzo.com.

At Senzo we are working to accelerate the home healthcare movement by developing and deploying fast, simple, accurate and affordable tests that anybody can use for a range of illnesses and diseases. #healthcarerevolution #remotemedicine #hometesting wsj.com/articles/heath…

According to @Bloomberg , Apple is making real progress in adding continuous glucose monitoring to the Apple Watch - the potential here is huge with 1 in 10 Americans having diabetes and using intermittent skin pricks to monitor glucose levels. #xj4y7vzkg" target="_blank" rel="nofollow noopener">bloomberg.com/news/articles/…

telegraph.co.uk/global-health/…](telegraph.co.uk/global-health/…

With the development of new multiplex tests, detecting flu, COVID-19, and RSV in a single diagnostic is becoming fast, affordable, and simple. These tests will become a staple of at-home healthcare better-tuning illness to treatment. #healthcare #diagnostics #innovation